Author

E. Ari

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 3 Approach:experimental assay· 2 Organism:human· 2 Approach:statistical model· 2 Organism:bacteria (other)· 1 Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Assay:metagenomics· 1

Frequent Co-Authors

B. Kintses· 4 shared B. Papp· 4 shared C. Pal· 4 shared M. Szamel· 4 shared B. M. Vasarhelyi· 3 shared G. Fekete· 3 shared L. Daruka· 3 shared A. Györkei· 2 shared

Activity by Year

2018-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersMicrobiology

B. Kintses

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Pathogen genomic surveillance as a scalable framework for precision phage therapy

M. Koncz, T. Stirling, H. Hadj Mehdi, O. Mehi, B. Eszenyi, A. Asboth, G. Apjok, A. Toth, L. Orosz, B. M. Vasarhelyi, E. Ari, L. Daruka, T. F. Polgar, G. Schneider, S. A. Zalokh, , B. Kintses

This paper develops a scalable framework for precision phage therapy by combining genomic surveillance and phage typing to target carbapenem-resistant Acinetobacter baumannii.

bioRxiv · Jun 15, 2024 · PreprintMicrobiology

Antibiotics of the future are prone to resistance in Gram-negative pathogens

L. Daruka, M. S. Czikkely, P. Szili, Z. Farkas, D. Balogh, G. Grezal, E. Maharramov, T.-H. Vu, L. Sipos, S. Juhasz, A. Dunai, A. Daraba, M. Szamel, T. Sari, T. Stirling, , C. Pal

This study shows new antibiotics are as likely to face resistance as existing ones in Gram-negative bacteria, highlighting the need for narrow-spectrum therapies.

bioRxiv · Jul 23, 2023Microbiology

Chemical-genetic profiling reveals cross-resistance and collateral sensitivity between antimicrobial peptides

B. Kintses, P. K. Jangir, G. Fekete, M. Szamel, O. Mehi, R. Spohn, L. Daruka, A. Martins, A. Hosseinnia, A. Gagarinova, S. Kim, S. Phanse, B. Csörgö, A. Györkei, E. Ari, , B. Papp

This study uses a chemical-genetic approach to analyze resistance determinants of E. coli to 15 AMPs, revealing cross-resistance and collateral sensitivity patterns.

bioRxiv · Feb 8, 2019 · PreprintMicrobiology

Phylogenetic barriers to horizontal transfer of antimicrobial peptide resistance genes in the human gut microbiota

B. Kintses, O. K. Mehi, E. Ari, M. Szamel, A. Györkei, P. K. Jangir, I. Nagy, F. Pal, G. Fekete, R. Tengölics, A. Nyerges, I. Liko, B. Balint, B. M. Vasarhelyi, M. Bustamante, , C. Pal

This study investigates the horizontal transfer of antimicrobial peptide resistance genes in the human gut microbiota, finding that their transfer rates and functional compatibility are lower than antibiotic resistance genes.

bioRxiv · Aug 7, 2018Microbiology